The objective of this study is to evaluate intermittent fasting after the treatment of breast cancer with surgery and radiation therapy. All participants will either delay their first meal of the day or advance their last meal to achieve an approximate 16-18 hour fasting period four times per week. Over six months, the innovative protocol will 1) assess adherence, and is expected to 2) improve body composition, quality of life and inflammatory and metabolic variables linked with outcomes after breast cancer treatment. The long-term goal of this project is to incorporate this dietary strategy as a standard component of care for breast cancer patients.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
16-18 hour fasting period four times per week
Duke Cancer Center
Durham, North Carolina, United States
Adherence to the intermittent fasting program
as determined by the proportion of fasting days met divided by the total fasting days planned for each participant
Time frame: 6 months
Change in body fat
as measured by mean change in percent body fat between baseline and 6 months
Time frame: baseline, 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.